Predictors and Trends of Hepatitis B Virus Transmissions in Selected Regions of Kenya
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Sites
2.2. Study Population and Recruitment
2.3. Data Management and Analysis
2.4. Ethical Considerations
3. Results
3.1. Prevalence and Sociodemographic Factors Associated with Hepatitis B Infection
3.2. Trends of Hepatitis B Infection by Age Group and Gender
3.3. Trends of HBV Infection Among Related Families
3.4. Behavioral, Traditional, and Cultural Practices and Hepatitis B Infection
3.5. Bivariable Analysis of Behavioral, Traditional, and Cultural Practices
4. Discussion
5. Conclusions
Recommendations
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| aPRs | Prevalence ratios |
| HCC | Hepatocellular carcinoma |
| HBsAg | Hepatitis B surface antigen |
| HBV | Hepatitis B virus |
| KEMRI | Kenya Medical Research Institute’s |
| LMIC | Low- and middle-income countries |
| NASCOP | National AIDS and STI Control Program |
| WHO | World Health Organization |
Appendix A
| Age Group in Years | No. of Participants n (%) | No. of HBV Infected n | Proportion (%) of HBV Infected Within: | |||
|---|---|---|---|---|---|---|
| Age Group | The Total Population | The Infected Population | ||||
| ≤19 | 167 | (5.6) | 3 | (1.8) | (0.1) | (1.6) |
| 20–24 | 387 | (13.0) | 14 | (3.6) | (0.5) | (7.4) |
| 25–29 | 408 | (13.7) | 23 | (5.6) | (0.8) | (12.2) |
| 30–34 | 366 | (12.3) | 23 | (6.3) | (0.8) | (12.2) |
| 35–39 | 350 | (11.7) | 30 | (8.6) | (10.0) | (15.9) |
| 40–44 | 239 | (8.0) | 20 | (8.4) | (0.7) | (10.6) |
| 45–49 | 176 | (5.9) | 23 | (13.1) | (0.8) | (12.2) |
| 50–54 | 215 | (7.2) | 18 | (8.4) | (0.6) | (9.5) |
| 55–59 | 148 | (5.0) | 8 | (5.4) | (0.3) | (4.2 |
| 60–64 | 163 | (5.5) | 9 | (5.5) | (0.3) | (4.8) |
| 65–69 | 126 | (4.2) | 8 | (6.4) | (0.3) | (4.2) |
| 70–74 | 119 | (4.0) | 6 | (5.0) | (0.2) | (3.2) |
| 75–79 | 61 | (2.0) | 4 | (6.6) | (0.1) | (2.1) |
| 80–84 | 41 | (1.4) | 0 | (0.0) | (0.0) | (0.0) |
| ≥85 | 21 | (0.7) | 0 | (0.0) | (0.0) | (0.0) |
| Total | 2987 | 100.0 | 189 | 6.3 | 6.3 | 100 |
References
- World Health Organization. Global Hepatitis Report 2024: Action for Access in Low-and Middle-Income Countries; World Health Organization: Geneva, Switzerland, 2024. [Google Scholar]
- Bigna, J.J.; Kenne, A.M.; Hamroun, A.; Ndangang, M.S.; Foka, A.J.; Tounouga, D.N.; Lenain, R.; Amougou, M.A.; Nansseu, J.R. Gender development and hepatitis B and C infections among pregnant women in Africa: A systematic review and meta-analysis. Infect. Dis. Poverty 2019, 8, 16. [Google Scholar] [CrossRef] [Scilit]
- Al-Busafi, S.A.; Al-Harthi, R.; Al-Naamani, K.; Al-Zuhaibi, H.; Priest, P. Risk Factors for Hepatitis B Virus Transmission in Oman. Oman Med. J. 2021, 36, e287. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Spearman, C.W.; Afihene, M.; Ally, R.; Apica, B.; Awuku, Y.; Cunha, L.; Dusheiko, G.; Gogela, N.; Kassianides, C.; Kew, M.; et al. Hepatitis B in sub-Saharan Africa: Strategies to achieve the 2030 elimination targets. Lancet Gastroenterol. Hepatol. 2017, 2, 900–909. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ondondo, R.O.; Muthusi, J.; Oramisi, V.; Kimani, D.; Ochwoto, M.; Young, P.; Ngugi, C.; Waruru, A.; Mwangi, J.; Chao, A.; et al. Prevalence of hepatitis B virus infection in Kenya: A study nested in the Kenya Population-based HIV Impact Assessment 2018. PLoS ONE 2024, 19, e0310923. [Google Scholar] [CrossRef] [Scilit]
- Kilonzo, S.B.; Gunda, D.W.; Mpondo, B.C.T.; Bakshi, F.A.; Jaka, H. Hepatitis B Virus Infection in Tanzania: Current Status and Challenges. J. Trop. Med. 2018, 2018, 4239646. [Google Scholar] [CrossRef] [Scilit]
- Kafeero, H.M.; Ndagire, D.; Ocama, P.; Kudamba, A.; Walusansa, A.; Sendagire, H. Prevalence and predictors of hepatitis B virus (HBV) infection in east Africa: Evidence from a systematic review and meta-analysis of epidemiological studies published from 2005 to 2020. Arch. Public Health 2021, 79, 167. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ochwoto, M.; Kimotho, J.H.; Oyugi, J.; Okoth, F.; Kioko, H.; Mining, S.; Budambula, N.L.M.; Giles, E.; Andonov, A.; Songok, E.; et al. Hepatitis B infection is highly prevalent among patients presenting with jaundice in Kenya. BMC Infect. Dis. 2016, 16, 101. [Google Scholar] [CrossRef] [Scilit]
- Ngaira, J.A.; Kimotho, J.; Mirigi, I.; Osman, S.; Ng’ang’a, Z.; Lwembe, R.; Ochwoto, M. Prevalence, awareness and risk factors associated with Hepatitis B infection among pregnant women attending the antenatal clinic at Mbagathi District Hospital in Nairobi, Kenya. Pan. Afr. Med. J. 2016, 24, 315. [Google Scholar]
- Songtanin, B.; Chaisrimaneepan, N.; Mendóza, R.; Nugent, K. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis B Virus Infections. Viruses 2024, 16, 618. [Google Scholar] [CrossRef] [Scilit]
- Brook, G.; Chawla, Y. Hepatitis viruses. In Sexually Transmitted Infections-E-Book; Elsevier Health Sciences: Bengaluru, India, 2013; p. 380. [Google Scholar]
- Zoulim, F.; Mason, W.S. Reasons to consider earlier treatment of chronic HBV infections. Gut 2012, 61, 333–336. [Google Scholar] [CrossRef] [Scilit]
- Ishizaki, A.; Bouscaillou, J.; Luhmann, N.; Liu, S.; Chua, R.; Walsh, N.; Hess, S.; Ivanova, E.; Roberts, T.; Easterbrook, P. Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low-and middle-income countries. BMC Infect. Dis. 2017, 17, 129–140. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ansari, A.; Vincent, J.P.; Moorhouse, L.; Shimakawa, Y.; Nayagam, S. Risk of early horizontal transmission of hepatitis B virus in children of uninfected mothers in sub-Saharan Africa: A systematic review and meta-analysis. Lancet Glob. Health 2023, 11, e715–e728. [Google Scholar] [CrossRef] [Scilit]
- Indolfi, G.; Easterbrook, P.; Dusheiko, G.; Siberry, G.; Chang, M.-H.; Thorne, C.; Bulterys, M.; Chan, P.L.; El-Sayed, M.H.; Giaquinto, C.; et al. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol. Hepatol. 2019, 4, 466–476, Correction in Lancet Gastroenterol. Hepatol. 2020, 5, e4. [Google Scholar] [CrossRef] [Scilit]
- Hou, J.; Liu, Z.; Gu, F. Epidemiology and Prevention of Hepatitis B Virus Infection. Int. J. Med. Sci. 2005, 2, 50–57. [Google Scholar] [CrossRef] [Scilit]
- Shepard, C.W.; Finelli, L.; Fiore, A.E.; Bell, B.P. Epidemiology of Hepatitis B and Hepatitis B Virus Infection in United States Children. Pediatr. Infect. Dis. J. 2005, 24, 755–760. [Google Scholar] [CrossRef] [Scilit]
- Allain, J.-P.; Opare-Sem, O. Screening and diagnosis of HBV in low-income and middle-income countries. Nat. Rev. Gastroenterol. Hepatol. 2016, 13, 643–653. [Google Scholar] [CrossRef] [Scilit]
- Terrault, N.A.; Lok, A.S.F.; McMahon, B.J.; Chang, K.-M.; Hwang, J.P.; Jonas, M.M.; Brown, R.S., Jr.; Bzowej, N.H.; Wong, J.B. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018, 67, 1560–1599. [Google Scholar] [CrossRef] [Scilit]
- Morikawa, K.; Shimazaki, T.; Takeda, R.; Izumi, T.; Umumura, M.; Sakamoto, N. Hepatitis B: Progress in understanding chronicity, the innate immune response, and cccDNA protection. Ann. Transl. Med. 2016, 4, 337. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zhang, Z.; Wang, C.; Liu, Z.; Zou, G.; Li, J.; Lu, M. Host Genetic Determinants of Hepatitis B Virus Infection. Front. Genet. 2019, 10, 696. [Google Scholar] [CrossRef] [Scilit]
- World Health Organization. Hepatitis Report; World Health Organization: Geneva, Switzerland, 2017. [Google Scholar]
- Jaquet, A.; Muula, G.; Ekouevi, D.K.; Wandeler, G. Elimination of viral hepatitis in low and middle-income countries: Epidemiological research gaps. Curr. Epidemiol. Rep. 2021, 8, 89–96. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Mutisya, I.; Muthoni, E.; Ondondo, R.O.; Muthusi, J.; Omoto, L.; Pahe, C.; Katana, A.; Ngugi, E.; Masamaro, K.; Kingwara, L.; et al. A national household survey on HIV prevalence and clinical cascade among children aged ≤15 years in Kenya (2018). PLoS ONE 2022, 17, e0277613. [Google Scholar] [CrossRef] [Scilit]
- Owino, N.; Kamau, G.; Kulundu, J.; Njuguna, A.; Tukei, P.M.; Yano, M.; Naruse, T. KEMRI Hep-cell II hepatitis B surface antigen screening kit. East Afr. Med. J. 1999, 76, 530–532. [Google Scholar] [PubMed]
- Schweitzer, A.; Horn, J.; Mikolajczyk, R.T.; Krause, G.; Ott, J.J. Estimations of worldwide prevalence of chronic hepatitis B virus infection: A systematic review of data published between 1965 and 2013. Lancet 2015, 386, 1546–1555. [Google Scholar] [CrossRef] [Scilit]
- Kazmi, S.A.; Rauf, A.; Alshahrani, M.M.; Al Awadh, A.A.; Iqbal, Z.; Soltane, R.; Tag-Eldin, E.; Ahmad, A.; Ansari, Z.; Rehman, Z.U. Hepatitis B among University Population: Prevalence, Associated Risk Factors, Knowledge Assessment, and Treatment Management. Viruses 2022, 14, 1936. [Google Scholar] [CrossRef] [Scilit]
- Brown, R.; Goulder, P.; Matthews, P.C. Sexual Dimorphism in Chronic Hepatitis B Virus (HBV) Infection: Evidence to Inform Elimination Efforts. Wellcome Open Res. 2022, 7, 32. [Google Scholar] [CrossRef] [PubMed]
- Liu, M.; Li, L.; Zhao, J.; Ungvari, G.S.; Ng, C.H.; Duan, Z.; Zheng, S.-J.; Xiang, Y.-T. Gender differences in demographic and clinical characteristics in patients with HBV-related liver diseases in China. PeerJ 2022, 10, e13828. [Google Scholar] [CrossRef] [Scilit]
- Ruggieri, A.; Barbati, C.; Malorni, W. Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity. Int. J. Cancer 2010, 127, 499–504. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Blumberg, B.S. Sex differences in response to hepatitis b virus. Arthritis Rheum. 1979, 22, 1261–1266. [Google Scholar] [CrossRef] [Scilit]
- Xu, X.; Wu, C.; Lou, Z.; Peng, C.; Jiang, L.; Wu, T.; Zeng, T.; Dong, Y.; Ruan, B. Changing incidence of hepatitis B and persistent infection risk in adults: A population-based follow-up study from 2011 in China. BMC Public Health 2023, 23, 256. [Google Scholar] [CrossRef] [Scilit]
- Stroffolini, T.; Esvan, R.; Biliotti, E.; Sagnelli, E.; Gaeta, G.B.; Almasio, P.L. Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease. J. Med. Virol. 2015, 87, 1899–1903. [Google Scholar] [CrossRef] [Scilit]
- Chu, C.-M.; Sheen, I.-S.; Lin, S.-M.; Liaw, Y.-F. Sex Difference in Chronic Hepatitis B Virus Infection: Studies of Serum HBeAg and Alanine Aminotransferase Levels in 10,431 Asymptomatic Chinese HBsAg Carriers. Clin. Infect. Dis. 1993, 16, 709–713. [Google Scholar] [CrossRef] [Scilit]
- Tang, L.S.Y.; Covert, E.; Wilson, E.; Kottilil, S. Chronic Hepatitis B Infection: A Review. JAMA 2018, 319, 1802–1813. [Google Scholar] [CrossRef] [Scilit]
- Abel, A.G.; Shamarina, S.; Hisham, M.; Hafiz, A.R.A. Prevalence and Associated Risk Factors of Hepatitis B Virus Infection in Lafia Metropolis, Nasarawa State, Nigeria. Afr. J. Infect. Dis. 2025, 19, 45–56. [Google Scholar] [PubMed]
- World Health Organization. Preventing Perinatal Hepatitis B Virus Transmission: A Guide for Introducing and Strengthening Hepatitis B Birth Dose Vaccination; World Health Organization: Geneva, Switzerland, 2015. [Google Scholar]
- Seto, W.-K.; Lo, Y.-R.; Pawlotsky, J.-M.; Yuen, M.-F. Chronic hepatitis B virus infection. Lancet 2018, 392, 2313–2324. [Google Scholar] [CrossRef] [Scilit]
- Athalye, S.; Khargekar, N.; Shinde, S.; Parmar, T.; Chavan, S.; Swamidurai, G.; Pujari, V.; Panale, P.; Koli, P.; Shankarkumar, A.; et al. Exploring risk factors and transmission dynamics of Hepatitis B infection among Indian families: Implications and perspective. J. Infect. Public Health 2023, 16, 1109–1114. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Mangowi, I.; Mirambo, M.M.; Kilonzo, S.B.; Mlewa, M.; Nyawale, H.; Majinge, D.; Hyera, F.; Jaka, H.; Mtemisika, C.; Michael, F.; et al. Hepatitis B virus infection, associated factors, knowledge and vaccination status among household contacts of hepatitis B index cases in Mwanza, Tanzania. IJID Reg. 2024, 10, 168–173. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sofian, M.; Banifazl, M.; Ziai, M.; Aghakhani, A.; Farazi, A.A.; Ramezani, A. Intra-familial Transmission of Hepatitis B Virus Infection in Arak, Central Iran. Iran. J. Pathol. 2016, 11, 328–333. [Google Scholar]
- Morgan, C.E.; Ngimbi, P.; Boisson-Walsh, A.J.N.; Ntambua, S.; Matondo, J.; Tabala, M.; Kashamuka, M.M.; Emch, M.; Edwards, J.K.; Powers, A.K.; et al. Hepatitis B Virus Prevalence and Transmission in the Households of Pregnant Women in Kinshasa, Democratic Republic of Congo. Open Forum Infect. Dis. 2024, 11, ofae150. [Google Scholar] [CrossRef] [Scilit]
- Jafari, S.; Buxton, J.A.; Afshar, K.; Copes, R.; Baharlou, S. Tattooing and risk of hepatitis B: A systematic review and meta-analysis. Can. J. Public Health 2012, 103, 207–212. [Google Scholar] [CrossRef] [Scilit]
- Chuang, S.C.; Lee, Y.C.; Hashibe, M.; Dai, M.; Zheng, T.; Boffetta, P. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: A meta-analysis. Cancer Epidemiol. Biomark. Prev. 2010, 19, 1261–1268. [Google Scholar] [CrossRef] [Scilit]
- Liu, X.; Baecker, A.; Wu, M.; Zhou, J.; Yang, J.; Han, R.; Wang, P.; Jin, Z.; Liu, A.; Gu, X.; et al. Interaction between tobacco smoking and hepatitis B virus infection on the risk of liver cancer in a Chinese population. Int. J. Cancer 2018, 142, 1560–1567. [Google Scholar] [CrossRef] [Scilit] [PubMed]


| Variables | N (%) | HBsAg+ n (%) | cPR | 95% CI | p-Value | aPR | 95% CI | p-Value |
|---|---|---|---|---|---|---|---|---|
| Region (n = 3033) | ||||||||
| Baringo | 2788 (91.9) | 189 (6.8) | 1 | REF | ||||
| Kisumu | 245 (8.1) | 3 (1.2) | 0.18 | 0.06, 0.56 | 0.003 | |||
| Sex (n = 3011) | ||||||||
| Female | 1969 (65.4) | 122 (6.2) | 1 | REF | ||||
| Male | 1042 (34.6) | 69 (6.6) | 0.94 | 0.70, 1.24 | 0.648 | |||
| Education Level (n = 2560) | ||||||||
| Up to Primary | 1195 (46.7) | 86 (7.3) | 0.998 | 0.65, 1.54 | 0.995 | 0.67 | 0.42, 1.06 | 0.085 |
| Secondary | 1031 (40.3) | 52 (5.0) | 0.70 | 0.50, 0.98 | 0.037 | 1 | REF | |
| College | 334 (13.1) | 24 (7.2) | 1 | REF | ||||
| Marital status (n = 3002) | ||||||||
| Never married | 425 (14.2) | 16 (3.2) | 1 | REF | 1 | REF | ||
| Married | 2431 (81.0) | 169 (7.0) | 2.18 | 1.31, 3.60 | 0.002 | 1 | ||
| Once married | 146 (4.9) | 3 (4.4) | 1.36 | 0.41, 4.55 | 0.616 | 1.36 | 0.47, 3.05 | 0.568 |
| Age of youngest child (n = 1891) | ||||||||
| >5 years | 682 (36.1) | 49 (7.2) | 1 | REF | ||||
| ≤5 years | 1209 (64.9) | 95 (7.9) | 1.1 | 0.77, 1.58 | 0.596 | |||
| Number of siblings in the family (n = 2872) | ||||||||
| <5 | 1597 (55.6) | 71 (4.5) | 1 | REF | 1 | REF | ||
| 5–10 | 1153 (40.2) | 97 (8.4) | 1.89 | 1.44, 2.71 | <0.001 | 1.40 | 0.65, 3.05 | 0.390 |
| >10 | 122 (4.3) | 9 (7.38 | 2.17 | 1.34, 3.51 | 0.001 | 1.43 | 0.26, 7.83 | 0.681 |
| Employment (n= 2969) | ||||||||
| Formal (Salaried) | 301 (10.1) | 19 (6.3) | 1 | REF | ||||
| Informal (Self-Employed) | 830 (27.9) | 62 (7.5) | 1.18 | 0.72, 1.94 | 0.507 | |||
| Unemployed | 1838 (61.9) | 105 (5.7) | 0.91 | 0.56, 1.45 | 0.679 | |||
| Net monthly income (USD) of the unemployed (n = 1119) | ||||||||
| <50 | 259 (23.1) | 12 (4.6) | 1 | REF | ||||
| 51–100 | 477 (42.6) | 40 (8.4) | 1.81 | 0.97, 3.39 | 0.064 | |||
| >101 | 383 (34.2) | 28 (7.3) | 1.57 | 0.82, 3.03 | 0.177 | |||
| Distance (n = 1313) | ||||||||
| <1 km | 96 (7.3) | 2 (2.1) | 1 | REF | 1 | REF | ||
| 1–5 km | 1046 (79.7) | 44 (4.2) | 2.06 | 0.49, 8.65 | 0.322 | 2.30 | 0.52, 10.06 | 0.271 |
| >5 km | 171 (13.0) | 23 (13.5) | 7.3 | 1.68, 31.70 | 0.008 | 10.44 | 2.26, 49.37 | 0.003 |
| Age category using the median (n = 2987) | ||||||||
| ≤37 years | 1559 (52.2) | 82 (5.3) | 1 | |||||
| >37 years | 1428 (47.8) | 107 (7.5) | 2.191 | |||||
| Age category in years (n = 2987) | ||||||||
| ≤19 years | 167 (5.6) | 3 (1.8) | 1 | REF | 1 | REF | ||
| 20–29 years | 797 (26.6) | 3 (9.6) | 2.67 | 0.81, 8.76 | 0.106 | 0.33, 8.27 | 0.546 | |
| 30–39 years | 716 (24.0) | 53 (14.9) | 4.37 | 1.35, 14.16 | 0.014 | 1.58 | 0.28, 9.03 | 0.605 |
| 40–49 years | 415 (13.9) | 43 (21.4) | 6.32 | 1.93, 20.66 | 0.002 | |||
| 50–59 years | 363 (12.2) | 26 (13.7) | 4.21 | 1.26, 14.14 | 0.020 | 1.04 | 0.15, 7.10 | 0.701 |
| ≥60 years | 531 (17.8) | 27 (23.5) | 2.93 | 0.88, 9.78 | 0.081 | 0.56 | 0.07, 4.51 | 0.586 |
| Family Name¤ | Parents’ HBV Status | No. of Infected Siblings | Family Members Infected * | |||
|---|---|---|---|---|---|---|
| Mother | Father | Male n/Total | Female n/Total | Infection Among Siblings | ||
| Family 1 | Negative | Infected | 1/5 | 1/5 | 2/5 (40.0%) | 3/7 (42.9%) |
| Family 2 | Negative | Negative | 3/6 | 1/6 | 4/6 (66.7%) | 4/8 (50.0%) |
| Family 3 | NT | NT | 1/7 | 2/7 | 3/7 (42.9%) | 3/7 (42.9%) |
| Family 4 | Deceased of HCC | Negative | 1/4 | 3/4 | 4/4 (100%) | 3/5 (50.0%) |
| Family 5 | Negative | Infected | 2/6 | 1/6 | 3/6 (50.0%) | 4/8 (50.0%) |
| Family 6 | Deceased | Deceased | - | 1/2 | ½ (50.0%) | ½ (50.0%) |
| Total | 1/6 | 2/6 | 17/30 (56.7%) | 18/37 (48.6%) | ||
| Variables | N (%) | HBsAg-Positive | ||||||
|---|---|---|---|---|---|---|---|---|
| HbsAg + n (%) | cPR | 95% CI | p-Value | aPR | 95% CI | p-Value | ||
| Sharing household items (n = 3034) | ||||||||
| No | 2561 (84.4) | 145 (5.7) | 1 | REF | 1 | REF | ||
| Yes | 473 (15.5) | 47 (9.9) | 1.76 | 1.29, 2.40 | <0.001 | 2.60 | 1.54, 4.39 | <0.001 |
| Hair dressing and shaving (n = 3007) | ||||||||
| Do it myself | 112 (3.7) | 8 (7.1) | 1 | REF | ||||
| I use barber/salon | 2643 (87.9) | 163 (4.2) | 0.86 | 0.44, 1.71 | 0.674 | |||
| Not applicable | 252 (8.4) | 13 (5.16) | 0.72 | 0.30, 1.69 | 0.454 | |||
| Traditional circumcision (n = 3007) | ||||||||
| No | 1048 (34.9) | 48 (4.5) | 1 | REF | 1 | REF | ||
| Yes | 1959 (65.1) | 139 (7.1) | 1.55 | 1.13, 2.13 | 0.007 | 1.02 | 0.56, 1.88 | 0.040 |
| Shared circumcision sharps (n = 1956) | ||||||||
| No | 1228 (62.8) | 92 (7.49) | 1 | REF | ||||
| Yes | 728 (37.2) | 47 (6.5) | 0.86 | 0.61, 1.21 | 0.390 | |||
| Where circumcision took place (n = 1933) | ||||||||
| Home | 1918 (98.1) | 137 (7.1) | 1 | REF | ||||
| Hospital | 15 (0.8) | 0 (0) | 1 | <0.001 | ||||
| Number of sexual partners (n = 454) | ||||||||
| None | 302 (66.5) | 17 (5.6) | 1 | REF | ||||
| Two | 111 (24.5) | 7 (6.3) | 1.12 | 0.48, 2.63 | 0.794 | |||
| >2 | 41 (9.03) | 3 (7.32) | 1.30 | 0.40, 4.25 | 0.664 | |||
| History of alcohol consumption (n = 3007) | ||||||||
| No | 2307 (76.7) | 133 (5.7) | 1 | REF | 1 | REF | ||
| Yes | 700 (23.3) | 56 (8.00) | 1.39 | 1.03, 1.88 | 0.032 | 1.32 | 0.76, 2.32 | 0.320 |
| Frequency of alcohol uptake (n = 700) | ||||||||
| Daily | 83 (11.8) | 8 (9.6) | 1 | REF | ||||
| After 2 days | 18 (2.6) | 1 (5.6) | 0.58 | 0.08, 4.35 | 0.593 | |||
| Weekly | 33 (4.7) | 1 (3.0) | 0.31 | 0.04, 2.42 | 0.267 | |||
| Fortnightly | 15 (2.1) | 2 (13.3) | 1.38 | 0.32, 5.91 | 0.661 | |||
| At times | 551 (78.7) | 5 (9.6) | 0.99 | 0.34, 2.90 | 0.996 | |||
| History of smoking or use of tobacco (n = 3008) | ||||||||
| No | 2893 (96.2) | 181 (6.3) | 1 | REF | ||||
| Yes | 115 (3.8) | 7 (6.1) | 0.98 | 0.47, 2.04 | 0.961 | |||
| Received transfused blood (n = 3004) | ||||||||
| No | 2871 (95.6) | 183 (6.4) | 1 | REF | ||||
| Yes | 133 (4.4) | 6 (4.5) | 0.70 | 0.32, 1.57 | 0.394 | |||
| Are you diabetic? (n = 2998) | ||||||||
| No | 2987 (99.6) | 187 (6.3) | 1 | REF | ||||
| Yes | 11 (0.4) | 2 (18.2) | 2.90 | 0.82,10.25 | 0.098 | |||
| Sharing diabetic needle (n= 11) | ||||||||
| No | 10 (90.0) | 2 18.2) | 1 | REF | <0.001 | |||
| Yes | 1 (10.0) | 0 (0.0) | 1 | |||||
| Use of other injectable drugs (n = 3000) | ||||||||
| No | 2992 (99.7) | 186 (6.2) | 1 | REF | 1 | REF | ||
| Yes | 8 (0.3) | 2 (25.0) | 4.02 | 1.20, 13.47 | 0.024 | 6.71 | 1.34, 33.67 | 0.021 |
| Know your HIV status (n = 3005) | ||||||||
| No | 1329 (44.2) | 89 (6.7) | 1 | REF | ||||
| Yes | 1676 (55.8) | 100 (6.0) | 0.89 | 0.68, 1.17 | 0.411 | |||
| HIV status if known (n = 1680) | ||||||||
| Negative | 1619 (96.4) | 97 (6.0) | 1 | REF | ||||
| Positive | 61 (3.6) | 3 (4.9) | 1.22 | 0.40, 3.73 | 0.730 | |||
| Are you a health care worker? (n = 3034) | ||||||||
| No | 3006 (99.1) | 191 (6.4) | 1 | REF | ||||
| Yes | 28 (0.9) | 1 (3.6) | 0.58 | 0.08, 4.01 | 0.584 | |||
| History of incarceration (n = 3004) | ||||||||
| No | 2933 (97.6) | 188 (6.4) | 1 | REF | ||||
| Yes | 71 (2.4) | 1 (1.4) | 0.22 | 0.03, 1.54 | 0.128 | |||
| Have tattoos or traditional scarification (n = 2989) | ||||||||
| No | 2962 (99.1) | 187 (6.3) | 1 | REF | ||||
| Yes | 27 (0.9) | 2 (7.4) | 1.17 | 0.31, 4.49 | 0.815 | |||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Ochwoto, M.; Ondondo, R.O.; Matoke, L.M.; Tuitoek, G.; Ogwora, E.; Omari, S.W.; Mong’are, H.; Onoka, F.O.; Sigilai, E.; Kimotho, J.H.; et al. Predictors and Trends of Hepatitis B Virus Transmissions in Selected Regions of Kenya. LabMed 2026, 3, 5. https://doi.org/10.3390/labmed3010005
Ochwoto M, Ondondo RO, Matoke LM, Tuitoek G, Ogwora E, Omari SW, Mong’are H, Onoka FO, Sigilai E, Kimotho JH, et al. Predictors and Trends of Hepatitis B Virus Transmissions in Selected Regions of Kenya. LabMed. 2026; 3(1):5. https://doi.org/10.3390/labmed3010005
Chicago/Turabian StyleOchwoto, Missiani, Raphael O. Ondondo, Lydia Moraa Matoke, Gladys Tuitoek, Elizabeth Ogwora, Samuel W. Omari, Haron Mong’are, Francis Otieno Onoka, Esther Sigilai, James Hungo Kimotho, and et al. 2026. "Predictors and Trends of Hepatitis B Virus Transmissions in Selected Regions of Kenya" LabMed 3, no. 1: 5. https://doi.org/10.3390/labmed3010005
APA StyleOchwoto, M., Ondondo, R. O., Matoke, L. M., Tuitoek, G., Ogwora, E., Omari, S. W., Mong’are, H., Onoka, F. O., Sigilai, E., Kimotho, J. H., Rono, R., Otedo, A., Were, V., & Matoke-Muhia, D. (2026). Predictors and Trends of Hepatitis B Virus Transmissions in Selected Regions of Kenya. LabMed, 3(1), 5. https://doi.org/10.3390/labmed3010005

